. Author manuscript; available in PMC: 2014 Jul 1.

Published in final edited form as: J Pediatr. 2013 Feb 16;163(1):261–267. doi: 10.1016/j.jpeds.2012.12.096

Table 1.

Demographics and clinical characteristics

	All patients (n=80)	Responders (n=44)	Non-responders (n=36)	P value
Age (y)	9.8 (0.75-20)	8.1 (0.75-20)	12.8 (1.6-20)	0.01
Sex	52 (65%) F	12 (27%) M	16 (44%) M	0.11
Weight (kg)	30.9 (7-145)	25.1 (7-106)	38.8 (9.6-145)	0.01
GES	43 (0-99)	51 (0-89)	34 (8-99)	0.42
Dose (mg/kg)	0.19 (0.04-0.6)	0.22 (0.04-0.6)	0.17 (0.04-0.6)	0.17
Treatment duration	20 (2-222)	23.5 (4-222)	12 (2-86)	<0.01

Values expressed as median (range). SE: side effects, Y: years, GES: percentage of gastric emptying at 1 hour, Treatment duration in weeks